Doctor profile · Federal record
Dr. ALI ZIAOLHAGH
Nephrology Physician (CMS: NEPHROLOGY) · HOUSTON, TX
- NPI 1780997494
- Accepts Medicare
- MIPS 81.3 / 100 · 2023
- 23 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6431 FANNIN ST # 5.136, 713-500-6881
HOUSTON, TX 770301501
(713) 500-6881 - Mailing address
-
6431 FANNIN ST. MSB 5.134
HOUSTON, TX 770302719
Credentials & registration
- NPI registered
- July 2010 — 16 yrs on file
- Profile last updated
- July 18, 2022
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207RN0300X — NUCC code
- State license (1)
- Texas #Q7620
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1780997494. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
392
Distinct HCPCS
8
Medicare allowed
$43,908
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 183 | 73 | $82 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 51 | 26 | $132 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 41 | 40 | $134 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 36 | 20 | $123 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 30 | 29 | $179 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 28 | 28 | $168 | |
99239 |
Hospital discharge day management, more than 30 minutes | 12 | 12 | $118 | |
90935 |
Hemodialysis procedure with physician evaluation | 11 | 11 | $74 |
In context: peer comparison
Among 76 peers in this city , average services per provider: 140. This provider delivers 2.8× the peer median.Open Payments
Industry payments received
All-time total
$346
Transactions
9
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $111.54 | |
| Daiichi Sankyo Inc. | 1 | $110.25 | |
| Novartis Pharmaceuticals Corporation | 2 | $44.82 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32.19 | |
| AstraZeneca Pharmaceuticals LP | 2 | $28.62 | |
| Ardelyx, Inc. | 1 | $18.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
201
Patients
50
Total drug cost
$51,588
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Nifedipine Er (Nifedipine) | Brand | 59 | 26 | $2,190 |
| Furosemide | Generic | 28 | 13 | $206 |
| Torsemide | Generic | 27 | 0 | $488 |
| Jardiance (Empagliflozin) | Brand | 23 | 0 | $30,094 |
| Bumetanide | Generic | 18 | 11 | $1,000 |
| Chlorthalidone | Generic | 18 | 0 | $364 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 16 | 0 | $17,107 |
| Carvedilol | Generic | 12 | 0 | $139 |